Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Meredith Mundy
i-Lumen Scientific, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cerulea
East Melbourne, Victoria, Australia
Active, not recruiting
- Auckland Eye Limited
Remuera, Auckland, New Zealand
Riyaz BhikooRecruiting
- Queens University Belfast / Belfast City Hospital
Belfast, United Kingdom
Tunde PetoRecruiting - King'S College Hospital
London, United Kingdom
Timothy Jackson, PhD, FRCOphthRecruiting - London North West University Healthcare
Middlesex, United Kingdom
Christiana Dinah, BSc, MB BS, MRes, FRCOphthRecruiting - Sunderland Eye Infirmary
Sunderland, United Kingdom
Ajay KotagiriRecruiting
- Retina Consultants San Diego
Poway, California, United States
Nicholas London, MDRecruiting - Retina Consultants Pc
Manchester, Connecticut, United States
Noam Rudnick, MDRecruiting - University Retina & Macula Associates
Lemont, Illinois, United States
Recruiting - Sierra Eye Associates
Reno, Nevada, United States
Arshad KhananiNot, yet, recruiting - Texas Retina Associates
Fort Worth, Texas, United States
Patrick Williams, MDRecruiting - Tyler Retina Research Insitute
Tyler, Texas, United States
Samuel Minaker, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 May 2025
- Primary completion
- 31 Mar 2027
- Completion
- 31 Dec 2029
- Last update posted
- 11 Aug 2026
- Registered enrollment
- 100
- Registry id
- NCT06662162
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.